These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 34157482)
1. Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma. Price G; Bouras A; Hambardzumyan D; Hadjipanayis CG EBioMedicine; 2021 Jul; 69():103453. PubMed ID: 34157482 [TBL] [Abstract][Full Text] [Related]
2. The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies. Persson ML; Douglas AM; Alvaro F; Faridi P; Larsen MR; Alonso MM; Vitanza NA; Dun MD Neuro Oncol; 2022 Sep; 24(9):1408-1422. PubMed ID: 35481923 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876 [TBL] [Abstract][Full Text] [Related]
4. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma. Pachocki CJ; Hol EM J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059 [TBL] [Abstract][Full Text] [Related]
18. CAR T cell therapies for diffuse midline glioma. Thomas BC; Staudt DE; Douglas AM; Monje M; Vitanza NA; Dun MD Trends Cancer; 2023 Oct; 9(10):791-804. PubMed ID: 37541803 [TBL] [Abstract][Full Text] [Related]
19. Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma. du Chatinier A; Meel MH; Das AI; Metselaar DS; Waranecki P; Bugiani M; Breur M; Simonds EF; Lu ED; Weiss WA; Garcia Vallejo JJ; Hoving EW; Phoenix TN; Hulleman E Neurooncol Adv; 2022; 4(1):vdac079. PubMed ID: 35733514 [TBL] [Abstract][Full Text] [Related]
20. CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas. Das AK; Sinha M; Singh SK; Chaudhary A; Boro AK; Agrawal M; Bhardwaj S; Kishore S; Kumari K Acta Neurol Belg; 2024 Aug; 124(4):1251-1261. PubMed ID: 38669002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]